InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
71%
T+90 mean return
+2.3%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by COLES N ANTHONY, Director. Director active across 2 companies, notably Regeneron Pharmaceuticals, INC.. Cumulatively, 35 reports have been recorded. Activity tracked since 13 August 2021. The latest transaction was filed on 2 January 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations35 total
166 shares0Common StockSEC:0001968202-25-000010:0
15,638 sharesCommon StockSEC:0000950170-24-090789:0
25,000 shares@ US$3.502.9% of flowCommon StockSEC:0000950170-24-081490:0
10,290 sharesCommon StockSEC:0000950170-24-070736:0
50,000 shares@ US$3.505.7% of flowCommon StockSEC:0000950170-24-069284:0
50,000 shares@ US$3.505.8% of flowCommon StockSEC:0000950170-24-059788:0
50,000 shares@ US$3.505.8% of flowCommon StockSEC:0000950170-24-041073:0
50,000 shares@ US$3.505.8% of flowCommon StockSEC:0000950170-24-027156:0
50,000 shares@ US$3.505.8% of flowCommon StockSEC:0000950170-24-025036:0
15,440 sharesCommon StockSEC:0000950170-24-012953:0
50,000 shares@ US$3.505.7% of flowCommon StockSEC:0000950170-24-001864:0
135 shares0Common StockSEC:0001968202-24-000029:0
22,824 shares@ US$3.502.7% of flowCommon StockSEC:0000950170-23-064517:0
27,076 shares@ US$3.503.2% of flowCommon StockSEC:0000950170-23-062217:0
38,599 shares@ US$3.504.6% of flowCommon StockSEC:0000950170-23-059520:0
50,000 shares@ US$3.505.9% of flowCommon StockSEC:0000950170-23-047297:0
50,000 shares@ US$3.505.7% of flowCommon StockSEC:0000950170-23-032878:0
50,000 shares@ US$3.505.8% of flowCommon StockSEC:0000950170-23-026502:0
50,000 shares@ US$3.505.7% of flowCommon StockSEC:0000899243-23-012418:0
50,000 shares@ US$3.505.7% of flowCommon StockSEC:0000950170-23-012731:0
47,000 shares@ US$3.505.5% of flowCommon StockSEC:0000899243-23-007176:0
50,000 shares@ US$3.505.8% of flowCommon StockSEC:0000899243-23-004360:0
50,000 shares@ US$3.505.9% of flowCommon StockSEC:0000899243-23-001184:0
165 shares0Common StockSEC:0001883850-23-000012:0
2,145 shares@ US$374.129.7% of flowCommon StockSEC:0001883850-22-000143:0
25 of 35 declarations
About COLES N ANTHONY
Anthony N. Coles is a Director at Regeneron Pharmaceuticals, Inc. He contributes to the governance of the company by providing his expertise and advice to the board of directors. His role involves overseeing operations and ensuring that decisions made are in the best interest of shareholders.
